Study of Clinical and Biomarker Analysis to Understand Acute Heart Failure and Cardiogenic Shock Outcomes in Hospitalized Adults

What this Trial Is About

Researchers are studying adults hospitalized with acute heart failure and cardiogenic shock to understand whether information collected during routine hospital care, along with blood and urine samples, can help doctors better identify types of cardiogenic shock and predict patient outcomes. The study focuses on whether clinical findings, imaging results, and biomarkers, including factors specific to sex, relate to the risk of death within 30 days. This observational study does not involve experimental treatments. Participants will have data collected from their routine hospital care and will provide extra blood and urine samples for future research storage. The study follows participants after they leave the hospital to observe outcomes over time. No new treatments are administered during the study. During the study, researchers will monitor participants through routine care records and additional sample collections. They will assess outcomes such as mortality at 30 days, as well as mortality and rehospitalization rates at 6 and 12 months after discharge. The total participation time varies depending on individual hospital discharge and follow-up periods.

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE